How workplace menopause support reduces absenteeism & boosts performance

Quick answer: Workplace menopause support reduces absenteeism and performance issues by giving employees confidential access to menopause-trained clinicians, personalised symptom management, and earlier intervention — before symptoms escalate into extended sick leave or resignation. CIPD research shows supported employees report significantly less negative work impact (71%) than unsupported ones (84%), and unsupported women are around five times more likely to leave their job.

Menopause is one of the biggest drivers of avoidable absence and performance dips in the UK workforce and most employers still don't have a system in place to catch it early.

The scale is easy to underestimate until you look at the numbers. CIPD's survey of over 2,000 working women found that 67% said menopause had a negative impact on their work, up from 59% just four years earlier. More than half (53%) had been unable to go into work at some point because of their symptoms. And according to the House of Commons Women and Equalities Committee's report on menopause and the workplace, around a third of women say they've taken time off specifically because of symptoms, with lost working days running into the millions across the UK economy every year.

That's not a small HR issue. It's a workforce-wide performance and retention problem hiding in plain sight and one that's getting harder to ignore, with voluntary menopause reporting arriving under the Employment Rights Act from April 2026, becoming mandatory from 2027. Peppy's guide to menopause action plans and what UK employers must do before 2027 covers the reporting requirements in more detail.

Why menopause symptoms translate into absence and underperformance

Menopause symptoms aren't limited to hot flushes. Sleep disturbance, brain fog, anxiety, joint pain and heavy periods can persist for years, and they can show up at work as missed deadlines, dropped concentration, and, eventually, sick days logged under something else entirely, because most employees still don't feel able to name menopause as the reason.

That last point matters commercially. Unlabelled absence is unmanageable absence. If a line manager doesn't know menopause is behind a pattern of sick days or a dip in someone's output, they can't respond appropriately, and the employee gets no route to support. The problem compounds rather than resolves and it isn't isolated to menopause; Peppy sees the same pattern across other under-disclosed women's health conditions where employees stay quiet until performance is already affected.

How workplace menopause support reduces absenteeism

Workplace menopause support services intervene at this gap. It turns a silent, unmanaged issue into something an employee can act on early, with expert input, before it escalates into extended absence or a resignation.

Three things tend to make the difference:

1. Confidential access to expert care. Employees can speak to menopause-trained clinicians without going through a line manager or GP waiting list, which are often the two biggest barriers to getting help in time.

2. Practical, personalised adjustments. Rather than a generic policy document, employees get guidance specific to their symptoms and role: adjusted hours during a bad flare-up, temperature or workload changes, or support having a conversation with their manager.

3. Earlier intervention. Because support is available before symptoms become severe, employees are far less likely to reach the point of extended sick leave or leaving altogether.

Peppy's menopause support service is built around exactly this model of confidential, clinician-led, early-stage support.

The performance and retention case, in numbers HR can use

For HR and benefits leaders building a business case, the argument is about absence management, retention, and productivity, with menopause as one of the largest and most preventable contributors.

• Absence is measurable and reducible. A third of women in the CIPD survey had taken time off for symptoms; workplace support directly targets that figure by intervening before symptoms force someone out.
• Retention risk is real and costly. NHS Employers points out that employers are losing roughly one in six women from the workforce due to inadequate menopause support. This is a direct hit to institutional knowledge, recruitment cost, and team continuity.
• Regulatory pressure is increasing. With menopause reporting requirements phasing in under the Employment Rights Act, employers who already have a support service in place won't be scrambling to build one under scrutiny.
• Presenteeism is the hidden cost. Even employees who don't take time off report reduced concentration and output while symptomatic. This is a cost that doesn't show up on an absence report but shows up everywhere else.

Peppy's case studies show how this plays out for real employers, from engagement rates through to reported impact on absence and retention.

A framework for Menopause Action Plans

Download here

Building the case internally

None of this requires an exhaustive audit before you can act. The clearest first step is understanding what "good" workplace menopause support in your organisation would be and how this differs to what you currently have in place.

If you're scoping this out for your organisation, our guide How to Choose Menopause Support at Work in 2026 walks through what to look for in a provider — from clinical credibility to line manager training to how outcomes get reported back to HR. It's worth reading alongside Peppy's menopause support for employees page, which sets out what a specialist workplace service includes.

FAQ

What is workplace menopause support?

Workplace menopause support is an employer-funded service that gives employees confidential access to menopause-trained clinicians, symptom guidance, and practical workplace adjustments — typically through a digital platform, one-to-one appointments, or a combination of both, rather than through a line manager or standard occupational health referral.

Does menopause support actually reduce sickness absence?

Evidence points that way. CIPD research shows employees who feel supported by their employer report a significantly less negative impact from menopause than those who don't (71% vs 84%), and unsupported women are around five times more likely to leave their job - both of which feed directly into absence and turnover figures. The mechanism is early intervention: support that catches symptoms before they force someone off work entirely.

How is workplace menopause support different from a menopause policy?

A policy sets out an organisation's commitment and process on paper. Workplace menopause support is the service that actually delivers on it — confidential clinical access, personalised adjustments, and manager guidance that an employee can use in the moment, rather than a document they read once during onboarding.

Is menopause support only relevant to large employers?

No. Symptom impact on attendance and performance scales with headcount, so mid-sized employers see the same proportional effect on absence and retention as large ones and with the Employment Rights Act reporting requirement extending to more employers over time, mid-sized organisations have as much reason to act early.

What's the business case for HR and benefits leaders?

The case rests on three measurable levers: reduced absence (fewer employees reaching the point of taking time off for symptoms), improved retention (avoiding the roughly one-in-six women employers lose due to inadequate support), and reduced presenteeism (better concentration and output from employees managing symptoms with proper support). Regulatory reporting requirements add a compliance dimension on top.